carbapenems and Microbial Superinvasion
carbapenems has been researched along with Microbial Superinvasion in 4 studies
Research
Studies (4)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Al Dhahri, F; Al Enazi, H; Al Muqati, H; Al Turaiki, A; Althemery, A | 1 |
Al-Tawfiq, JA; Eljaaly, K; Enani, MA | 1 |
Paño Pardo, JR; Pintado, V; Ramos Ramos, JC; Serrano Villar, S | 1 |
Benjamin, DK; Cotten, CM; Goldberg, RN; McDonald, S; Poole, K; Stoll, B | 1 |
Reviews
2 review(s) available for carbapenems and Microbial Superinvasion
Article | Year |
---|---|
Impact of carbapenem versus non-carbapenem treatment on the rates of superinfection: A meta-analysis of randomized controlled trials.
Topics: Anti-Bacterial Agents; Antimicrobial Stewardship; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Humans; Pneumonia; Randomized Controlled Trials as Topic; Risk Factors; Superinfection; Treatment Outcome | 2018 |
Infections caused by carbapenemase-producing Enterobacteriaceae: risk factors, clinical features and prognosis.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Carrier State; Comorbidity; Cross Infection; Disease Susceptibility; Drug Resistance, Multiple, Bacterial; Endemic Diseases; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Postoperative Complications; Prognosis; Risk Factors; Superinfection; Travel | 2014 |
Other Studies
2 other study(ies) available for carbapenems and Microbial Superinvasion
Article | Year |
---|---|
Superinfection rate among the patients treated with carbapenem versus piperacillin/tazobactam: Retrospective observational study.
Topics: Adult; Aged; Anti-Bacterial Agents; Carbapenems; Female; Humans; Male; Middle Aged; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Superinfection; Treatment Outcome | 2021 |
The association of third-generation cephalosporin use and invasive candidiasis in extremely low birth-weight infants.
Topics: Blood; Candidiasis; Carbapenems; Catheterization, Central Venous; Central Nervous System Fungal Infections; Cephalosporins; Cerebrospinal Fluid; Comorbidity; Cross Infection; Enterocolitis, Necrotizing; Fungemia; Gram-Negative Bacterial Infections; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Infant, Very Low Birth Weight; Prospective Studies; Registries; Risk Factors; Superinfection | 2006 |